BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9213241)

  • 1. Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro.
    Myojo S; Tsujikawa T; Sasaki M; Fujiyama Y; Bamba T
    J Gastroenterol; 1997 Jun; 32(3):300-5. PubMed ID: 9213241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas.
    Hashimoto N; Ohyanagi H; Kazuyuki S
    J Pediatr Surg; 2003 Apr; 38(4):579-84. PubMed ID: 12677570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rat glicentin on intestinal adaptation in small intestine-resected rats.
    Hirotani Y; Taki M; Kataoka K; Kurokawa N; Satoh T; Sasaki K; Yanaihara C; Luo WQ; Yanaihara N
    Ann N Y Acad Sci; 1998 Dec; 865():601-5. PubMed ID: 9928077
    [No Abstract]   [Full Text] [Related]  

  • 4. Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat.
    Sasaki M; Fitzgerald AJ; Mandir N; Sasaki K; Wright NA; Goodlad RA
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1681-6. PubMed ID: 11564010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive effects of glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats.
    Hirotani Y; Yamamoto K; Yanaihara C; Balaspiri L; Yanaihara N; Kurokawa K
    Ann N Y Acad Sci; 2000; 921():460-3. PubMed ID: 11193876
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
    Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
    Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch.
    Shibata C; Naito H; Jin XL; Ueno T; Funayama Y; Fukushima K; Hashimoto A; Matsuno S; Sasaki I
    Scand J Gastroenterol; 2001 Oct; 36(10):1049-55. PubMed ID: 11589377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
    Drucker DJ; Erlich P; Asa SL; Brubaker PL
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7911-6. PubMed ID: 8755576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
    Rouillé Y; Kantengwa S; Irminger JC; Halban PA
    J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats.
    Goodlad RA; Ghatei MA; Bloom SR; Wright NA
    Exp Physiol; 1991 Nov; 76(6):943-9. PubMed ID: 1768417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats.
    Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL
    Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxyntomodulin reduces hydromineral transport through rat small intestine.
    Beauclair F; Eto B; Pansu D; Rodier G; Mochizuki T; Martinez J; Bataille D; Jarrousse C
    Dig Dis Sci; 1998 Aug; 43(8):1814-23. PubMed ID: 9724174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trophic effect of glucagon-(1-21)-peptide on the isolated rat ileal mucosal cells.
    Watanabe N; Matsuyama T; Namba M; Miyagawa J; Itoh H; Komatsu R; Kono N; Tarui S
    Biochem Biophys Res Commun; 1988 May; 152(3):1038-44. PubMed ID: 3377764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglucagon processing in islet and intestinal cell lines.
    Tucker JD; Dhanvantari S; Brubaker PL
    Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulinotropic action of human glicentin in dogs.
    Ohneda A; Ohneda K; Nagasaki T; Sasaki K
    Metabolism; 1995 Jan; 44(1):47-51. PubMed ID: 7854165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration?
    Goodlad RA; Mandir N; Meeran K; Ghatei MA; Bloom SR; Playford RJ
    Regul Pept; 2000 Feb; 87(1-3):83-90. PubMed ID: 10710291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A target cell to oxyntomodulin and glicentin: the antral smooth muscle cell.
    Rodier G; Magous R; Mochizuki T; Bali JP; Bataille D; Jarrousse C
    Ann N Y Acad Sci; 1998 Dec; 865():458-62. PubMed ID: 9928049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.